- Report
- May 2025
- 193 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 195 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 186 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 199 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 196 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 181 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 198 Pages
Global
From €3172EUR$3,545USD£2,746GBP
€3524EUR$3,939USD£3,051GBP
- Report
- May 2025
- 170 Pages
Global
From €5324EUR$5,950USD£4,608GBP
- Report
- April 2025
- 307 Pages
Global
From €4026EUR$4,500USD£3,485GBP
- Report
- July 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- April 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- April 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- March 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €4017EUR$4,490USD£3,477GBP
- Report
- July 2025
- 168 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 739 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- November 2024
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- June 2025
- 400 Pages
Global
From €4428EUR$4,949USD£3,833GBP
- Report
- May 2023
- 150 Pages
Global
From €5324EUR$5,950USD£4,608GBP

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases.
Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more